[HTML][HTML] COVID-19 infection causing residual gastrointestinal symptoms–a single UK centre case series

J Cooney, P Appiahene, R Findlay, L Al-Hillawi… - Clinical …, 2022 - ncbi.nlm.nih.gov
Although COVID-19 was first recognised as an acute respiratory illness, extra-pulmonary
manifestations are increasingly being recognised. Acute gastrointestinal side effects have been …

Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second …

…, RCG Pollok, T Ng, P Appiahene… - Alimentary …, 2022 - Wiley Online Library
Background Anti‐drug antibodies are associated with treatment failure to anti‐TNF agents in
patients with inflammatory bowel disease (IBD). Aim To assess whether immunogenicity to …

O38 1mg once daily orodispersible budesonide can maintain clinical remission in adults with eosinophilic oesophagitis

J Cooney, P Appiahene, I Ranasinghe, J Hayat - 2023 - gut.bmj.com
Introduction Orodispersible budesonide (ODB) is an effective induction treatment for adults
with eosinophilic oesophagitis (EoE) at 1mg twice daily (BD), however optimal maintenance …

P149 Post-gastroscopy oesophageal carcinoma–a 10 year single centre case series

J Cooney, P Appiahene, A Wolak, H Chong, J Hayat - 2023 - gut.bmj.com
Introduction UGI cancer detected within 5 years of a gastroscopy (termed post-OGD UGI
cancer – POUGIC) may reflect delayed diagnosis and contribute to poorer prognosis. It has …

O39 Importance of human-machine interaction in detection of Barrett's Neoplasia using a novel deep neural network in the era of AI

H Htet, K Siggens, M Saiko, N Maeda… - 2023 - gut.bmj.com
Introduction Despite improvements in endoscopic imaging modalities, there are still significant
miss rates in detecting Barrett’s neoplasia. We have previously reported the development …

P147 Proton-pump inhibitors as 1st line therapy in eosinophilic oesophagitis–simple and more effective than originally thought

A Hadjinicolaou, S Kateroglou, MT Sharip, I Modolell - 2023 - gut.bmj.com
Introduction Eosinophilic oesophagitis (EO) has emerged as an increasingly common
gastrointestinal condition over the last few decades and is characterised by dense eosinophilic …

O37 Real world implementation of non-endoscopic triage testing for Reflux disease and Barrett's oesophagus during COVID-19

R Landy, WK Tan, S Killcoyne, M di Pietro, C Tang… - 2023 - gut.bmj.com
Introduction COVID-19 significantly curtailed endoscopic services in the UK. The
oesophageal cell collection device- Cytosponge with biomarkers, was green-lighted for pilot …

Ifeanyi Ezeonu, Brock University, Canada

H Pepinsky - api.taylorfrancis.com
There is a huge gap in knowledge on criminology of people of African descent, especially
on the African continent. The existing texts are few and are inadequate, especially because …

The Impact of Information Technology on Healthcare: Factors that Influence the Selection of Healthcare Technologies to Impact Healthcare Delivery: A Case Study of …

EA Amoah - 2021 - search.proquest.com
… I also dedicate this dissertation to my amazing wife (Priscilla Keelson-Amoah), my sister (Ophelia
Karl), and my younger brother (Isaac Kwakye) for pushing me to complete this study in …

Predicting anti-TNF treatment failure in patients with inflammatory bowel disease

N Chanchlani - 2024 - ore.exeter.ac.uk
About one-third of patients with inflammatory bowel disease (IBD) are treated with anti-TNF
therapy. Unfortunately, treatment failure is common, and only about one-third of patients …